{"nct_id":"NCT01682083","title":"Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2013-01-08","start_date_type":"ACTUAL","primary_completion_date":"2017-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}